CC · NYSE · Diversified Chemicals
Diversified Chemicals company based in Wilmington, Delaware.
In the last 90 days, insiders of Chemours reported 7 open-market purchases worth about $489K and 0 open-market sales. Every figure links to its official SEC, House, Senate or USAspending record.
Last closeLast close, Oct 5, 2026
$13.89
Last 12 months
Not enough history
Market value
$2.09B
Revenue
$1.59B
−1.5% vs the same quarter a year earlier
Free cash flow, last 12 months
$218M
This quarter $114M, a year earlier $50M
Net debt
$3.2B
Debt $3.87B, cash $671M, at Jun 30, 2026
Backlog
$122M
Work contracted but not yet delivered, as the company reports it
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Aug 4, 2026.
Insiders buying, last 90 days
7 insiders
$489K bought in total
Insiders selling, last 90 days
None
No open-market sales reported
New federal contracts, 12 months
None
Nothing found for this company
Revenue, fiscal 2025
$5.81B
+0.4% vs the year before
Net income, fiscal 2025
−$386M
A loss for the year
Shares outstanding
150M
As of Jul 30, 2026
In fiscal 2025 the company spent $78M on dividends. Cash actually paid, from its cash-flow statement.
Stock since the trade −6.2% · S&P 500 +0.6% · to Oct 5
The boss of Chemours paid $51K out of pocket for Chemours shares. 6 other people at Chemours bought some too, in the same month.
Stock since the trade −8.9% · S&P 500 +0.3% · to Oct 5
Chemours's See Remarks paid $30K out of pocket for Chemours shares. 6 other people at Chemours bought some too, in the same month.
Stock since the trade −11.8% · S&P 500 +0.2% · to Oct 5
A board member of Chemours paid $203K out of pocket for Chemours shares. 6 other people at Chemours bought some too, in the same month. The Chemours shares held grew by 30%.
Stock since the trade −11.8% · S&P 500 +0.2% · to Oct 5
A board member of Chemours paid $95K out of pocket for Chemours shares. 6 other people at Chemours bought some too, in the same month. The Chemours shares held grew by 6%.
Stock since the trade −11.8% · S&P 500 +0.2% · to Oct 5
Chemours's See Remarks paid $30K out of pocket for Chemours shares. 6 other people at Chemours bought some too, in the same month.
Prices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
Top officer leaving
“If a Participant (i) is involuntarily terminated without Cause (as defined in the Policy) or (ii) resigns for Good Reason (as defined in the Policy), the Company will provide the following payments and benefits to the Participant, subject to applicable tax withholding and certain exceptions as described in the Policy: Compensation Chief Executive Officer (“CEO”) Other Executive Officers and Employ”
8-K on sec.govFrom the company's 8-K, 10-K and 10-Q filings over the last two years. A flag is a reason to read the filing, not a verdict: many departures are planned retirements and many listing notices are resolved. Insider sales are shown for timing only; they are separate filings.
Last 12 months, adjusted daily closes
Adjusted close went from $15.80 on Oct 6, 2025 to $13.89 on Oct 5, 2026 (-12.1%). Disclosed activity in the last 12 months: 7 insider purchases, 0 insider sales, 0 Congress purchases, 0 Congress sales. 1 group of purchases by several insiders within a few days.
